FDA-approved for correcting moderate-to-severe facial wrinkles and folds, Restylane DEFYNE from the Emervel Collection is a hyaluronic acid-based dermal implant meant for injection into the deep dermis and the upper subcutaneous layer. Lidocaine is included in the filler’s formulation to make certain patients are comfortable during treatments.
Dermal filler Restylane DEFYNE is recommended for treating deeper wrinkles and is especially appropriate for administration in the area around the mouth. Created using XpresHAn Technology, the product has bigger gel particles and more extensive crosslinks between hyaluronic acid molecules. This makes dermal filler Restylane DEFYNE firm and well-suited for providing volume and lift, leading to more dramatic rejuvenation. While dermal filler Restylane DEFYNE provides enough volume that it can be used to enhance cheeks and fill in hollows, it is still soft enough to have outstanding flexibility. This ensures patients won’t have the dreaded artificial expressions that can happen when a filler does not integrate well into the zone where it is placed.
Dermal filler Restylane DEFYNE is indicated for treating Nasolabial Folds, Oral Commissures, and Marionette Lines and for enhancing the forehead and the cheeks and temples. Since many patients experience very little swelling after a treatment with Restylane DEFYNE, downtime is minimal. Effects have great longevity and can last up to a year. Occasional touch-up visits can help extend the duration of outcomes.
Dermal filler Restylane DEFYNE from the Emervel Collection is manufactured by Galderma in Europe.
It is made of highly crosslinked hyaluronic acid that is not of animal origin, and it comes in a prefilled syringe with 1 ml of gel accompanied by 2 x 27G1/2” needles. The concentration of hyaluronic acid in dermal filler Restylane DEFYNE is 20 mg/ml, while Lidocaine is present at a concentration is 3mg/ml.